CVA Family Office’s Dentsply Sirona XRAY Stock Holding History

CVA Family Office’s Portfolio XRAY Stock Details XRAY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$3.91K	Buy	337 +212	+170%	+$2.64K	﹤0.01%	1318
2025 Q4	$1.43K	Buy	+125	New	+$1.47K	﹤0.01%	1041
2025 Q3	–	Sell	-78	Closed	-$1.24K	–	1350
2025 Q2	$1.24K	Sell	78 -46	-37%	-$688	﹤0.01%	1060
2025 Q1	$1.85K	Buy	+124	New	+$2.2K	﹤0.01%	1019
2023 Q3	–	Sell	-95	Closed	-$3.8K	–	981
2023 Q2	$3.8K	Hold	95	–	–	﹤0.01%	832
2023 Q1	$3.73K	Buy	95 +75	+375%	+$2.75K	﹤0.01%	808
2022 Q4	$637	Buy	+20	New	+$603	﹤0.01%	888
2022 Q3	–	Sell	-75	Closed	-$3K	–	948
2022 Q2	$3K	Sell	75 -205	-73%	-$8.29K	﹤0.01%	813
2022 Q1	$14K	Hold	280	–	–	﹤0.01%	630
2021 Q4	$16K	Buy	+280	New	+$15.4K	﹤0.01%	567
2021 Q3	–	Sell	-140	Closed	-$9K	–	904
2021 Q2	$9K	Hold	140	–	–	﹤0.01%	687
2021 Q1	$9K	Buy	+140	New	+$8.12K	﹤0.01%	542

Other funds holding XRAY

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

SCA

Southpoint Capital Advisors New York $4.86B AUM 34.09% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Cooke & Bieler Philadelphia, Pennsylvania $8.84B AUM 6.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return

Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return

CVA Family Office's XRAY Position: Q1 2026 in Review

CVA Family Office increased its Dentsply Sirona (XRAY) stake by 170% in Q1 2026, buying an estimated $2.64K and bringing the position to 337 shares worth $3.91K. The position accounts for ﹤0.01% of the portfolio, ranked #1318.

CVA Family Office first reported a position in XRAY in Q1 2021 and has held it in 12 quarters since. The position peaked at $16K in Q4 2021. 382 funds tracked by Wall St. Rank hold XRAY as of Q1 2026.

CVA Family Office held 337 shares of Dentsply Sirona worth $3.91K as of Q1 2026.
CVA Family Office bought 212 Dentsply Sirona shares in Q1 2026, an estimated $2.64K.
Dentsply Sirona made up ﹤0.01% of CVA Family Office's portfolio in Q1 2026, its #1318 holding.
CVA Family Office first reported a position in Dentsply Sirona in Q1 2021 and has held it in 12 quarters since.
CVA Family Office's Dentsply Sirona position peaked at $16K in Q4 2021.
382 funds tracked by Wall St. Rank held Dentsply Sirona as of Q1 2026.

Based on CVA Family Office's 13F filing for Q1 2026, filed 29 Apr 2026.